Responses to Regulated E-Cigarette Advertisements

Sponsor
University of Massachusetts, Worcester (Other)
Overall Status
Recruiting
CT.gov ID
NCT05207033
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)
120
1
2
8
14.9

Study Details

Study Description

Brief Summary

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. Specifically, the investigators will conduct a randomized control trial (RCT) where young adults are randomized to one of two conditions: 1) a regulated ad environment, with high impact EC ad features removed or 2) an unregulated ad environment, with high impact EC ad features left intact. Participants will view EC ads embedded in an online magazine 24 times over the course of 6 months. EC experimentation and sustained use will be the primary outcome of interest.

Condition or Disease Intervention/Treatment Phase
  • Other: Regulated ad condition
  • Other: Unregulated ad condition
N/A

Detailed Description

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco use is established. Additionally, the tobacco industry targets individuals of this age with the hope that they will one day progress to using combustible cigarettes. Advertising may be one of the reasons leading young people to use ECs, and the Food and Drug Administration (FDA) now has the authority to regulate EC advertisement features. The goal of the proposed study is to determine which EC ad features most strongly influence young adults' attitudes, susceptibility, and intentions to use ECs, and determine if the restriction of these ad features influences EC attitudes, experimentation, and sustained use. The investigators will experimentally estimate the causal effect of restricting high impact EC ad features on tobacco use behavior. Specifically, the investigators will conduct a randomized control trial (RCT) where young adults are randomized to one of two conditions: 1) a regulated ad environment, with high impact EC ad features removed or 2) an unregulated ad environment, with high impact EC ad features left intact. Participants will view EC ads embedded in an online magazine 24 times over the course of 6 months. EC experimentation and sustained use will be the primary outcome of interest. Findings from this study will provide public health officials important and urgently needed information as to what advertising features are contributing to the sharp rise in the use of ECs among young adults, and if restrictions reduce the use of ECs among young adults.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Young Adults' Responses to E-Cigarette Advertisement Features and the Effect of Restricting Features on Tobacco Use - Phase 2
Actual Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Unregulated ad condition

This arm will include exposure to unregulated e-cigarette ads or ads as they appear in modern media.

Other: Unregulated ad condition
This intervention will determine if unrestricted appealing features in e-cigarette ads deter young adults from trying the product.

Experimental: Regulated ad condition

This arm will include exposure to regulated e-cigarette ads or ads where we have taken out the appealing features.

Other: Regulated ad condition
This intervention will determine if restriction of appealing features in e-cigarette ads deter young adults from trying the product.

Outcome Measures

Primary Outcome Measures

  1. Tobacco Use [1 month]

    Use of any tobacco products

  2. Tobacco Use [3 months]

    Use of any tobacco products

  3. Tobacco Use [6 months]

    Use of any tobacco products

  4. Perceived severity of using E-Cigarettes [1 month]

    Perceived severity of using ECs will be assessed by participants' perceived significance, severity, and seriousness of health threats from EC use. The measure is as follows: Please rate the following statements on a scale from 1 (strongly disagree) to 5 (strongly agree). I believe that the health threat of using e-cigarettes is severe. I believe that the health threat of using e-cigarettes is serious. I believe that the health threat of using e-cigarettes is significant.

  5. Perceived severity of using E-Cigarettes [3 months]

    Perceived severity of using ECs will be assessed by participants' perceived significance, severity, and seriousness of health threats from EC use. The measure is as follows: Please rate the following statements on a scale from 1 (strongly disagree) to 5 (strongly agree). I believe that the health threat of using e-cigarettes is severe. I believe that the health threat of using e-cigarettes is serious. I believe that the health threat of using e-cigarettes is significant.

  6. Perceived severity of using E-Cigarettes [6 months]

    Perceived severity of using ECs will be assessed by participants' perceived significance, severity, and seriousness of health threats from EC use. The measure is as follows: Please rate the following statements on a scale from 1 (strongly disagree) to 5 (strongly agree). I believe that the health threat of using e-cigarettes is severe. I believe that the health threat of using e-cigarettes is serious. I believe that the health threat of using e-cigarettes is significant.

  7. Motivation to Avoid E-Cigarettes [1 Month]

    Motivation to avoid ECs including importance, confidence, and readiness to avoid ECs will be collected to assess for changes in motivations. The measure is as follows: How important is it to avoid e-cigarettes in the future? 0=Not important at all 10=Very important How confident are in avoiding e-cigarettes in the future? 0=Not confident at all 10=Very confident How ready are you to avoid e-cigarettes in the future? 0=Not ready at all 10=Very ready How committed are you to avoid e-cigarettes in the future? 0=Not committed at all 10=Very committed

  8. Motivation to Avoid E-Cigarettes [3 Months]

    Motivation to avoid ECs including importance, confidence, and readiness to avoid ECs will be collected to assess for changes in motivations. The measure is as follows: How important is it to avoid e-cigarettes in the future? 0=Not important at all 10=Very important How confident are in avoiding e-cigarettes in the future? 0=Not confident at all 10=Very confident How ready are you to avoid e-cigarettes in the future? 0=Not ready at all 10=Very ready How committed are you to avoid e-cigarettes in the future? 0=Not committed at all 10=Very committed

  9. Motivation to Avoid E-Cigarettes [6 Months]

    Motivation to avoid ECs including importance, confidence, and readiness to avoid ECs will be collected to assess for changes in motivations. The measure is as follows: How important is it to avoid e-cigarettes in the future? 0=Not important at all 10=Very important How confident are in avoiding e-cigarettes in the future? 0=Not confident at all 10=Very confident How ready are you to avoid e-cigarettes in the future? 0=Not ready at all 10=Very ready How committed are you to avoid e-cigarettes in the future? 0=Not committed at all 10=Very committed

  10. Behavioral Intentions Behavioral Intentions [1 month]

    Behavioral intentions will be evaluated using questions "How interested are you in trying ECs?," "How willing are you to try ECs?," 'How willing would you be to purchase an EC?," and "How willing would you be to try an EC if a friend offered you one?".

  11. Behavioral Intentions Behavioral Intentions [3 months]

    Behavioral intentions will be evaluated using questions "How interested are you in trying ECs?," "How willing are you to try ECs?," 'How willing would you be to purchase an EC?," and "How willing would you be to try an EC if a friend offered you one?".

  12. Behavioral Intentions Behavioral Intentions [6 months]

    Behavioral intentions will be evaluated using questions "How interested are you in trying ECs?," "How willing are you to try ECs?," 'How willing would you be to purchase an EC?," and "How willing would you be to try an EC if a friend offered you one?".

  13. Salivary Cotinine [1 month]

    Bioochemical confirmation of tobacco non-use will be conducted with salivary cotinine (~3 day nicotine biomarker).

  14. Salivary Cotinine [3 months]

    Bioochemical confirmation of tobacco non-use will be conducted with salivary cotinine (~3 day nicotine biomarker).

  15. Salivary Cotinine [6 months]

    Bioochemical confirmation of tobacco non-use will be conducted with salivary cotinine (~3 day nicotine biomarker).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 26 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 to 26 years old,

  • fluent in English (earn a score of at least 4 on the Rapid Estimate of Adult Literacy in Medicine)

  • biochemically confirmed abstinence of alcohol (BrAC=.00) and combusted tobacco or marijuana exhaled carbon monoxide (eCO<6 parts per million) at time of visit,

  • reporting never trying an e-cigarette, not even a puff OR reporting tried and e-cigarette in the past but not in the past 30 days. Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire, with only those identifying anything besides "no curiosity/interest" to all three susceptibility questions as susceptible users.

Exclusion Criteria:
  • Out of age range 18-26 years

  • Use of an e-cigarette in past 30 days

  • Pregnant women

Contacts and Locations

Locations

Site City State Country Postal Code
1 UMass Chan Medical School Stevens Lab Worcester Massachusetts United States 01605

Sponsors and Collaborators

  • University of Massachusetts, Worcester
  • National Institute on Drug Abuse (NIDA)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elise Stevens, Assistant Professor, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT05207033
Other Study ID Numbers:
  • H00022520
  • 4R00DA046563-04
First Posted:
Jan 26, 2022
Last Update Posted:
Jun 29, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 29, 2022